Related Experiment Video
Updated: Mar 23, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Lipoid Pneumonia and Sarcoidosis
Introduction:
Lipoid pneumonia is a rare, underdiagnosed disorder, and its combined presentation with sarcoidosis is even more unusual.
Methods:
This paper presents a case in which both lipoid pneumonia and sarcoidosis were present, and includes the relevant literature review on lipoid pneumonia.
Results:
Lipoid pneumonia may be acute or chronic in its presentation, resulting from exogenous or endogenous factors, or classified as idiopathic, with its precise incidence unknown. Radiographic changes maybe variable, but typically include lower lobe consolidation. Pathologic changes consist of an inflammatory giant cell reaction around lipid-related empty vacuoles and giant cell granulomas. Treatment in the case of exogenous lipoid pneumonia consists of removal of the offending oil ingestion. However, in endogenous lipoid pneumonia, treatment is aimed at the underlying cause, as there is no standard treatment. Repeated bronchoalveolar lavage, corticosteroids, and surgical resection have been used as therapies. The course of the disease is usually not progressive.
Insights
Lipoid pneumonia, a rare lung disorder, can co-occur with sarcoidosis. This case highlights the unusual combination and reviews lipoid pneumonia, noting variable presentations and treatments.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Lipoid pneumonia is a rare and often underdiagnosed lung condition.
- Its co-occurrence with sarcoidosis is exceptionally uncommon.
- This paper details a case study involving both conditions.
Observation:
- Lipoid pneumonia presents variably, either acutely or chronically.
- Causes can be exogenous (oil ingestion) or endogenous, with idiopathic cases also noted.
- Radiographic findings often show lower lobe consolidation.
Findings:
- Pathological hallmarks include giant cell granulomas and inflammatory reactions around lipid vacuoles.
- Treatment for exogenous lipoid pneumonia involves removing the causative agent.
- Endogenous lipoid pneumonia management targets the underlying cause; no standard treatment exists.
Implications:
- Therapeutic options like bronchoalveolar lavage, corticosteroids, and surgery have been employed.
- The disease course is typically non-progressive.
- Understanding this rare combination aids in diagnosis and management of complex pulmonary diseases.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Related Concept Videos
Atypical Pneumonia
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation